A geriatrician, former John Franklin Chair of Geriatrics and Director of the Glennan Center for Geriatrics and Gerontology at Eastern Virginia Medical School (1996-2007), and Director of Center for Geriatrics and Palliative Care at University Hospitals in Cleveland (2014-2017), he is now the David S. Greer Professor of Geriatrics and Professor in the departments of Medicine and Health Services Policy and Practice at Brown's schools of medicine and public health. He serves as the Director, Division of Geriatrics and Palliative Medicine at the Alpert Medical School of Brown University and Associate Director of the Center on Innovation in Long-Term Services and Supports at the Providence Veterans Administration Medical Center. Dr. Gravenstein has a long-standing interest in immunity, inflammation, cardiovascular outcomes and aging especially in the context of vaccines and the long-term care setting, and the topic of the majority of his publications. He also has a specific interest in quality improvement in health care, the culture of care, antimicrobial stewardship, and how to improve care transitions. Beginning in 2020, he became active in several projects related to COVID in long-term care. He was Clinical Director at Healthcentric Advisors, Medicare's Quality Improvement Organization for New England from 2007 to 2019. 

Nationality: Italian

Position: Research Director, CNR Ageing Branch, Neuroscience Institute, Padova (Italy)

Research Fields: Clinical epidemiology and geriatrics. Main focus on lifelong approach to healthy ageing

ESWI member since 2022

Dr. Stefania Maggi received her degree in Medicine and Surgery from the University of Padua, Italy in 1983. She also attended the Graduate School of Geriatrics and Gerontology from the same University until 1987 and in 1988 she received her Master in Public Health from John Hopkins University in Baltimore (USA). Dr. Maggi also holds a PhD in Clinical Pathophysiology from the University of Padua, which she received in 2000.

Dr. Maggi has a specific interest in the epidemiology of ageing and in the analysis of factors promoting health ageing in a lifelong approach. From 1983-1985, Dr. Maggi worked as an attending physician at the Internal Medicine Department for the University Hospital in Padua before she spent the years of 1988-1989 as a postdoctoral fellow at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), for the National Institute of Health (NIH) in Bethesda, Maryland (USA). From 1989-1993, she worked as the Coordinator for the WHO Program on Ageing, before she moved on to work as a researcher in the Ageing branch at the Institute of Neuroscience, Consiglio Nazionale Delle Ricerche (CNR), Padua. Dr. Maggi worked as a researcher from 1993-2007 before becoming Research Director for the same branch and institute, in 2007, a position she currently holds. In this position, she coordinates several national and international research projects on nutrition, vaccines and lifestyle as key factors for promoting healthy ageing. Dr. Maggi is also an Adjunct Professor in the Graduate Schools of Geriatric Medicine at the University of Padua, which she has been since 2000.

Moreover, Dr. Maggi is the Editor in Chief of “Ageing Clinical and Experimental Research” (Springer) and has more than 800 publications, both in peer-reviewed journals and many book chapters.

Nationality: German



Position: Professor of Pulmonary Infections Universities Giessen & Marburg Lung Center, and Head of the Infectious Diseases Department at the Giessen University Hospital, Giessen, Germany



Research fields: Influenza Viruses , pneumonia and coronaviruses



ESWI member from 2016 – 2022



Associate member since 2022



Professor Susanne Herold studied medicine at the University of Giessen from 1995 to 2002. She received her doctorate in 2003 with a thesis on monocytes in the lungs and acquired her PhD 2008 at the University of Giessen. Since 2013, she has been a visiting professor at Northwestern University in Chicago for the Department of Pulmonary and Intensive Care Medicine.



In 2018, Susanne Herold took over the professorship for infectious diseases of the lungs at the University of Giessen and at the same time became head of the Infectious Diseases Department at the Giessen University Hospital.



She has been a member of numerous specialist societies, including the Academy of Charitable Sciences in Erfurt and the German Center for Infection Research since 2017. She is also a member of the Scientific Advisory Board of the Robert Koch Institute and deputy chairman of the German Society for Infectious Diseases. Since 2016, Prof. Herold has been leading a DFG- funded clinical research project on lung damage caused by viruses.

Nationality: French



Position: Head of unit of Molecular Genetics of RNA viruses, Department of Virology, Institut Pasteur



Research fields: Epidemiological and virological surveillance of human influenza viruses and of other respiratory viruses



ESWI member from 1998 – 2022



Associate Member since 2022



Professor Sylvie van der Werf has a degree in Physiology and Biochemistry Agrégation (National Teaching Degree), a Doctorate in Microbiology with an option in Virology at the University of Paris, and a Doctorate in Natural Sciences specialising in Virology, also at the University of Paris.



She heads the unit of Molecular Genetics of RNA viruses which associates three research groups on influenza viruses (Epidemiology and evolution of respiratory viruses / Influenza virus-host cell interactions / Virus interactomics and one research group on hepaciviruses (Hepacivirus / host interactions). Professor van der Werf is also Director of the coordinating center of the National Reference Centre for influenza viruses and WHO National Influenza Center (NIC) for Northern France as well as WHO Reference Laboratory for H5 influenza viruses and for the SARS coronavirus (SARS-CoV).



Past research positions include: Deputy-Director of the Fundamental Virology Course, Deputy-Chairman of the Department of Virology, Director of the URA 1966 CNRS Molecular Virology Unit. She is the author of 70 original scientific papers and more than 30 other scientific publications.

Nationality: Dutch

Position: Retired General Practitioner and vocational trainer, Amersfoort, The Netherlands

Research fields: Clinical aspects of influenza vaccination

ESWI member since 2001

Dr. van Essen became a General Practitioner in 1976 and Vocational Trainer in 1981 based in Amersfoort, the Netherlands. He was also Assistant Professor (since 1992) at the Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht. Dr Van Essen obtained his degree at the University of Groningen (M.D. and G.P.) and at Utrecht University where he received his Ph.D.

He is chair of the Dutch Influenza Foundation. From 2000-2004, he was also the President of the Dutch College of General Practitioners. From 1996 to 2000 he was editor of Bijblijven, a Dutch CME-Journal.

Known on TV as Dr Ted, he is well known in The Netherlands for his work as a TV doctor, providing his medical insights for a wide and varied national audience. He was a member of the board of several leading healthcare institutions, including the Supervisory Board of Dimence, a large mental healthcare institution in Overijssel. 

Professor Terho Heikkinen graduated from the Medical School at the University of Turku in 1984, where he also specialized in Paediatrics and Paediatric Infectious Diseases. He defended his thesis on Development and prevention of acute otitis media in children in 1994. Having received the European Society for Paediatric Infectious Diseases Fellowship Award, he worked in 1996-1998 as a post-doc Research Fellow at the University of Texas Medical Branch at Galveston, USA. Subsequently, he worked as a Senior Clinical Researcher and Clinical Lecturer at the Department of Paediatrics, University of Turku. Since 2016, he has been Professor of Paediatrics at the Faculty of Medicine, University of Turku.

During the years, Terho Heikkinen has served as the chairman or a board member of several international and domestic societies in the field of paediatric infectious diseases, including the President of the World Society for Pediatric Infectious Diseases. He is a former board member of the European Scientific Working Group on Influenza (ESWI), a scientific advisory board and executive committee member of the global Respiratory Syncytial Virus Network (ReSViNET), and the chairman of the Nordic Research Network for Paediatric Infectious Diseases (NORDPID).

MD, DMSc, EIS, MPG, Public Health Specialist, Director of Clinical Research.

Background in public health, virology and epidemiology- specialized in virus epidemics. Professor at Univ. of Copenhagen, Denmark in Public Health, Virus Infections and Epidemics.

Prev. positions incl.: Dir. of the National WHO Influenza Centre & WHO Reference Labs for Measles, Rubella & Polio. Sen. Consultant and Head of the Virology Surv. and Research Unit at Statens Serum Institut (SSI), Staff specialist (inf. diseases & health system strengthening) & Acting Head of Int. Affairs at Nat. Board of Health, Resident in intern medicine at Rigshospitalet, Epi researcher at SSI, Denmark (PhD student and postdoc: epi. research incl. mathematical modelling of epidemics and vaccine efficacy), Virology researcher (cultivation, PCR, cloning and sequencing) and EIS (outbreak investigations: response/control of epidemics), CDC, Atlanta, USA and supervisor of Gastro Section at National Public Health Laboratory in Bissau, Guinea-Bissau.

(Co-)authoring >200 peer-reviewed publications (H-index: 42).

National representations for the European Center of Disease Prevention & Control (ECDC):

National Microbiology Focal Point (2012-2018)

National coordinator of the EU Progr. for Public Health Microb. training (EUPHEM) (2012-18)

Member of the Mol. Typing Task Force (2015-18)

Member of the ESCAIDE Scientific Committee (2012-17)

Main research focuses are related to pub. health applied virology incl. surveillance, epidemic control and vaccinology.

Leadership competencies & interests strengthend with a master in public governance at Cph Business School, (thesis "Benchmarking as budget-control tool at public hospitals").



Specialties:

• Member of The Royal Danish Academy of Sciences & Letters (2018)
• Master in Public Governance (2017)
• Professor (Adj SDU) Inf. Dis. & Global Health (2014)
• Public Health Specialist (2010)
• DMSc/Dr med (virology & epidemiology) 2002)
• Epidemic Intelligence Service Officer (EISO) (2003)
• MD (1994)

Formal education

05/2000: Habilitation, University of Vienna

March 1995: Graduation

10/88-01/95: Medical school, University of Vienna

1976-1988: Elementary and secondary school, Vienna



Professional experience

since 02/2001: Associate Professor, Institute of Social Medicine, Center for Public Health, Medical University Vienna

11/96-09/2000: Research Assistent, Institute of Social Medicine, University of Vienna

04/1995-11/96: Research Assistent, Institute of Tumorbiology&Cancer Research, Department of Epidemiology, University



Areas of Expertise:

Public Health in general, Public Health and vaccinations with specific focus on influenza and tick-borne encephalitis, pandemic planning, social marketing and public health, epidemiology of infectious diseases



Publications

approx. 100 scientific publications

numerous contributions in medical und lay press



Further Activites

Teaching activity at the Medical Universtiy Vienna

Membership of several oranisations and association, e.g. secretary general of the Austrian association of the promotion of education in vaccination matters

Nabila initiated her career as a medical officer, earning a Bachelor of Medicine and Surgery (MBBS) in 2013. Expanding her expertise, she specialized in microbiology, achieving a Doctor of Pathology (Medical Microbiology) from the National University of Malaysia (UKM) in 2022. Nabila underwent practical and bioinformatics training for Influenza and RSV Viral genomic sequencing by WHO, Melbourne. Currently, she serves as a clinical microbiologist in the Virology Unit at the Infectious Diseases Research Centre (IDRC), Institute for Medical Research (IMR), National Institute of Health (NIH), Malaysia.

Her role includes acting as the laboratory supervisor for the Molecular Virology Laboratory in the Virology Unit, IMR, NIH, overseeing diagnostic, surveillance, and research activities. The laboratory serves as the National Influenza Centre (NIC) and actively participates in WHO's Global Influenza and SARS-CoV-2 Surveillance. Preparing for expansion, the laboratory aims to incorporate RSV into the surveillance program. Nabila's interests extend to research and development, focusing on in-house RSV diagnostic tests (e.g., multiplex PCR and antigen lateral flow assay), whole-genome sequencing, and vaccine studies. Additionally, she plays a vital role as a member of the IMR's ISO 15189 implementation committee and actively engages in audit activities as a molecular diagnostic laboratories' auditor.

Beyond her laboratory responsibilities, Nabila is a student supervisor and lecturer for the Post-graduate Diploma of Medical Microbiology (DMM), Virology module, conducted by SEAMEO-TROPMED's Regional Centre for Microbiology, Parasitology, and Entomology.

Wolfgang Philipp is the acting director of the new DG Health Emergency Preparedness and Response Authority (HERA) in the European Commission. Prior to this, he was the Head of Unit for crisis management and preparedness in the Public Health, Country Knowledge, Crisis Management Directorate of the Commission. The unit would deal with activities contributing to preparedness and crisis management related to cross-border health threats, vaccination policy, antimicrobial resistance, HIV, tuberculosis, hepatitis policy, joint procurement of medical countermeasures, global health security and other files.



He holds a PhD in microbiology from the University of Paris, France, and has been working in tuberculosis research at the Institut Pasteur, and at the Universities of Bern and Basel. Philipp was a Member of the Basel Institute of Immunology before joining the European Commission in 2001.



PROVIDED BY HERA:



Mr Wolfgang Philipp is Acting Director of the new DG Health Emergency Preparedness and Response Authority (HERA) in the European Commission. HERA is dealing with:

• Developing the Health Emergency Preparedness and Response Authority
• Implementing the EU Vaccine Strategy to accelerate the development, manufacturing and deployment of COVID-19 vaccines
• Planning and implementing actions under the European bio-defence preparedness plan called 'HERA Incubator'

He holds a PhD in microbiology of the University of Paris, France, and has been working in tuberculosis research at the Institut Pasteur, and at the Universities of Bern and Basel and was a Member of the Basel Institute of Immunology before joining the European Commission in 2001.

Yoshi Kawaoka, Ph.D., is a globally recognised influenza expert and professor in the University of Wisconsin–Madison School of Veterinary Medicine. He was recognised with the 2017 Popular Mechanics Breakthrough Award for his efforts to understand and prevent pandemics.

He is an expert avian influenza virus and showed that a 1918-like pandemic influenze virus (Spanish flu) could be recreated again in nature. He also led a group that created a whole-virus vaccine against Ebola that was safe and effective in primates and traveled to Sierra Leone to learn more about the disease.

His work is also changing how flu vaccines are made by providing faster and more cost-effective methods. Kawaoka’s team established a new strategy to generate and manipulate the virus – a system called “reverse genetics” – that has revolutionised the field. In 2007 he co-founded FluGen, a Madison-based company dedicated to preventing and treating both seasonal and pandemic outbreaks that kill hundreds of thousands worldwide.

Kawaoka’s research looks at the Influenza virus: the molecular mechanism of interspecies transmission of the virus leading to influenza pandemics in humans; and the molecular pathogenesis of influenza in poultry and mammals. With the Ebola virus, he studies the role of viral proteins in pathogenesis and viral replication.

Kawaoka also teaches veterinary virology, providing background information in basic virology, as well as a clinically-oriented review of the pathogenesis, diagnosis and management of the major viral diseases of animals.

Shi Zhengli is a Chinese virologist who researches SARS-like coronaviruses of bat origin. Shi directs the Center for Emerging Infectious Diseases at the Wuhan Institute of Virology (WIV). In 2017, Shi and her colleague Cui Jie discovered that the SARS coronavirus likely originated in a population of cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan. She came to prominence in the popular press as “Batwoman” during the COVID-19 pandemic for her work with bat coronaviruses. Shi was included in Time’s 100 Most Influential People of 2020.



Shi graduated from Wuhan University in 1987 with a bachelor’s degree in genetics.She received her master’s degree from the Wuhan Institute of Virology of the Chinese Academy of Sciences (CAS) in 1990, and she received her PhD at the Montpellier 2 University in France in 2000.